"Carbapenems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.
Descriptor ID |
D015780
|
MeSH Number(s) |
D02.065.589.099.124 D03.633.100.300.124
|
Concept/Terms |
Carbapenems- Carbapenems
- Antibiotics, Carbapenem
- Carbapenem Antibiotics
|
Below are MeSH descriptors whose meaning is more general than "Carbapenems".
Below are MeSH descriptors whose meaning is more specific than "Carbapenems".
This graph shows the total number of publications written about "Carbapenems" by people in this website by year, and whether "Carbapenems" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2012 | 1 | 1 | 2 |
2016 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2019 | 0 | 2 | 2 |
2020 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
2022 | 2 | 0 | 2 |
2023 | 0 | 1 | 1 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbapenems" by people in Profiles.
-
The impact of colistin-based regimens on mortality compared to other antimicrobials in patients with carbapenem-resistant Enterobacterales bacteremia in South African hospitals: a cross-sectional study. BMC Infect Dis. 2024 Jun 05; 24(1):561.
-
Incidence, pathogens and antimicrobial resistance of blood and cerebrospinal fluid isolates from a tertiary neonatal unit in South Africa: A 10 year retrospective review. PLoS One. 2024; 19(1):e0297371.
-
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS). PLoS Med. 2023 Jun; 20(6):e1004179.
-
Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: An update. S Afr Med J. 2022 08 01; 112(8):542-552.
-
Comparison of carbapenem minimum inhibitory concentrations of Oxacillin-48-like Klebsiella pneumoniae by Sensititre, Vitek 2, MicroScan, and Etest. Clin Microbiol Infect. 2022 Dec; 28(12):1650.e1-1650.e5.
-
The novel application and effect of an ultraviolet light decontamination strategy on the healthcare acquisition of carbapenem-resistant Enterobacterales in a hospital setting. J Hosp Infect. 2022 Mar; 121:57-64.
-
Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018. Eur J Clin Microbiol Infect Dis. 2020 Jul; 39(7):1287-1294.
-
Genomic analysis of two drug-resistant clinical Morganella morganii strains isolated from UTI patients in Pretoria, South Africa. Lett Appl Microbiol. 2020 Jan; 70(1):21-28.
-
Perceived differences between intensivists and infectious diseases consultants facing antimicrobial resistance: a global cross-sectional survey. Eur J Clin Microbiol Infect Dis. 2019 Jul; 38(7):1235-1240.
-
The use of polymyxins to treat carbapenem resistant infections in neonates and children. Expert Opin Pharmacother. 2019 03; 20(4):415-422.